Among COVID-19 patients, there was no significant association between any of the antecedent lipid levels and the risk of hospitalization due to COVID-19, disease severity, mortality, or other inflammatory parameters (such as IL-6, ESR and procalcitonin), which may be due to inadequate power to assess these associations. This evidence concerns the gene IL6 and COVID-19.